VR Logo

Gufic Biosciences Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1984

Chairman: Jayesh P Choksi

Managing Director: Jayesh P Choksi

Group: --

Listing: NSE: GUFICBIO, BSE: 509079

Headquarters: Mumbai, Maharashtra

Website: www.gufic.com

Key Facts

Market cap: R 635.09 Cr

Revenue (TTM): R 319.50 Cr

Earnings (TTM): R 12.30 Cr

Cash: R 7.59 Cr

Total Debt: R 97.79 Cr

Promoters' ownership: 65.75%

Liquidity: Moderate

52 Week range: R 37.00 - 104.90

Face value: R1.00

Shares outstanding: 7,78,30,000

10 Years Aggregate:

  • CFO: 29.26 Cr
  • EBITDA: 183.11 Cr
  • Net Profit: 70.73 Cr

Stock Performance

Time Period Gufic Biosciences S&P BSE Healthcare S&P BSE Small Cap
YTD33.3347.718.50
1 month-7.432.89-0.85
3 months3.4220.3017.68
1 Year13.4955.9111.42
3 Years1.1313.94-2.30
5 Years17.092.386.36
10 Years28.2612.693.75
As on 28-Sep-2020
Year Gufic Biosciences S&P BSE Small Cap S&P BSE Healthcare
2019-35.40-6.85-3.55
2018-26.15-23.41-5.89
2017138.2559.640.49
2016-4.491.77-12.88
2015225.156.7615.06